Euro-Asian Master in Medical Technology and Healthcare Business (EMMaH)

EMMaH is a professionalising master that allows students to work in an international environment by combining theoretical analysis and concrete case studies in partnership with various health organisations.

Graduate are awarded a joint diploma co-signed by the EU partners, the MSc. from TMU (depending on the student’s choice for the Master thesis) and digital graduation certificates.

Consortium Partners

EMMaH is a joint and multidisciplinary master program held by four higher education institutions. EMMaH was created in 2015 by the three original funders (ULille, IPP Porto and HAW Hamburg) and enlarged with TMU Taipei in 2021. EMMaH was granted the prestigious ERASMUS MUNDUS Label in 2022 and the very first Mundus Cohort started in September 2023.

Mobility Program

The students enrolled in EMMaH master spend a first semester in Hamburg, Germany to study at HAW-Hamburg, a second semester at Porto, Portugal to study at IPP ; a third semester at Lille, France to study at UFR3S- Engineering and Management in Healthcare Business (ILIS).

This is possible to spend the 4th semester at Taipei (Taïwan) and write a master’s thesis at Taipei Medical University TMU on top of performing an internship in one of the TMU partner’s organizations.

The master thesis can be supervised by any of the participating Universities and an optional internship can be held anywhere in the world.

Curriculum Overview

The general objectives of this master are:

• To incorporate knowledge for the development of competences and skills within management and product marketing with applications in the medical field
• To enable students to adapt to change and overcome present and future challenges of the international market.

It also intends to push students to develop specific skills such as:

• understanding and developing different scenarios from medical, technical, clinical and economic points of views;
• developing methodological, social, cultural and personal skills;
• acquiring knowledge about product management and marketing in the medical field;
• being capable of engagement and flexibility in an international context. 

Finally it promotes contact between students with different educational experiences at European HEIs and an understanding of Asian experience. Thanks to the structure and content of the curriculum, students can achieve the following intended learning outcomes: process and interpret clinical data; apply business orientation to the healthcare; interact with multiple stakeholders such as hospitals, biotech companies or health institutions; imagine new technical and business solutions to enhance patients’ well-being.

Thus, EMMaH will contribute to enhance the attractiveness of European Higher Education around the world and attract talent to Europe through academic cooperation and individual mobility.

Aside from the relevance of these scientific areas to the expansion of the medical industry, the geographic locations of this consortium’s 4 institutions bring unique added value to attract excellent students from around the world.

Students enrolled in EMMaH have access to training, facilities, hospitals, and expertise not available in one academic setting alone and only possible through the consortium cooperation.